- Report
- April 2024
- 80 Pages
South Korea
From €1322EUR$1,500USD£1,150GBP
From €1322EUR$1,500USD£1,150GBP
- Report
- April 2024
- 80 Pages
United Kingdom
From €1322EUR$1,500USD£1,150GBP
- Report
- April 2024
- 80 Pages
United States
From €1322EUR$1,500USD£1,150GBP
- Report
- April 2024
- 140 Pages
Global
From €2785EUR$3,160USD£2,423GBP
€3481EUR$3,950USD£3,029GBP
- Report
- April 2024
- 114 Pages
Global
From €2785EUR$3,160USD£2,423GBP
€3481EUR$3,950USD£3,029GBP
- Report
- January 2024
- 146 Pages
Global
From €2996EUR$3,400USD£2,607GBP
€3745EUR$4,250USD£3,259GBP
- Report
- November 2023
- 140 Pages
Global
From €3137EUR$3,560USD£2,730GBP
€3922EUR$4,450USD£3,413GBP
- Report
- November 2023
- 117 Pages
Global
From €3966EUR$4,500USD£3,451GBP
- Report
- July 2023
- 113 Pages
Global
From €3966EUR$4,500USD£3,451GBP
- Report
- July 2023
- 119 Pages
Global
From €3966EUR$4,500USD£3,451GBP
- Report
- May 2023
- 116 Pages
Global
From €3966EUR$4,500USD£3,451GBP
- Report
- August 2022
- 116 Pages
Global
From €3966EUR$4,500USD£3,451GBP
- Report
- August 2022
- 120 Pages
Global
From €3966EUR$4,500USD£3,451GBP
- Report
- July 2024
- 200 Pages
Global
From €4361EUR$4,949USD£3,795GBP
- Report
- April 2024
- 140 Pages
Global
From €4361EUR$4,949USD£3,795GBP
- Report
- December 2023
- 170 Pages
Global
From €3172EUR$3,599USD£2,760GBP
- Report
- November 2023
- 172 Pages
Global
From €3172EUR$3,599USD£2,760GBP
- Report
- October 2023
- 140 Pages
Global
From €3172EUR$3,599USD£2,760GBP
- Report
- September 2023
- 140 Pages
Global
From €3172EUR$3,599USD£2,760GBP

The Contract Research Organization (CRO) market within the biotechnology sector is a rapidly growing industry. It provides services to biotechnology companies, such as drug discovery, preclinical and clinical trials, and regulatory affairs. CROs are often used to outsource research and development activities, allowing biotechnology companies to focus on their core competencies. CROs also provide access to specialized expertise and resources, such as specialized laboratory equipment and personnel.
CROs are increasingly being used to reduce costs and speed up the development process. They are also used to reduce the risk associated with drug development, as they can provide access to a wide range of expertise and resources.
Some of the major companies in the CRO market include Parexel, Quintiles, Charles River Laboratories, Covance, and PRA Health Sciences. Show Less Read more